NPR Health - Shots

NOVEMBER 5, 2022

In American Sirens, writer Kevin Hazzard recounts how a group of Black paramedics in Pittsburgh in the 1970s pioneered and professionalized the modern day ambulance service.

144

144

Clairnes

NOVEMBER 5, 2022

The post 4 ways to improve your Sjogren’s syndrome’s study enrollment rates appeared first on Clinical Trial Recruitment & Management Services.

Clinical Trials 76

Clinical Trials Clinical Trials Trials 76

NPR Health - Shots

NOVEMBER 5, 2022

Two reports from the CDC provided details on which groups have the highest death rates and which states are seeing the largest numbers.

138

138

Drug Patent Watch

NOVEMBER 5, 2022

Annual Drug Patent Expirations for CHANTIX Chantix is a drug marketed by Pf Prism Cv and is included in one NDA. It is available from four suppliers. There are two…. The post New patent expiration for Pf Prism drug CHANTIX appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Clinical Research

NPR Health - Shots

NOVEMBER 5, 2022

NPR's Scott Simon asks Dr. Douglas Carlson of the Southern Illinois University School of Medicine about a spike in RSV, respiratory syncytial virus, infections in children.

Medicine 72

Medicine 72

Drug Patent Watch

NOVEMBER 5, 2022

Annual Drug Patent Expirations for HORIZANT Horizant is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are six patents protecting…. The post New patent expiration for Azurity drug HORIZANT appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

Drug Patent Watch

NOVEMBER 5, 2022

[![eltrombopag structure]([link] Eltrombopag is the generic ingredient in two branded drugs marketed by Novartis and is included in two NDAs. There are eight patents protecting this compound. There are four…. The post New tentative approval for Teva Pharms drug eltrombopag appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 40

Drugs Branding Marketing 40

Drug Patent Watch

NOVEMBER 5, 2022

[![saxagliptin structure]([link] Saxagliptin is the generic ingredient in one branded drug marketed by Astrazeneca Ab and is included in one NDA. There are two patents protecting this compound. There are…. The post New tentative approval for Amneal Pharms drug saxagliptin appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 40

Drugs Branding Marketing 40

Drug Patent Watch

NOVEMBER 5, 2022

This chart shows the drugs with the most patents in Slovakia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Slovakia? appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs 52